October 2023
1. FORD AC, Wright-Hughes A, Alderson SL, Ow PL, et al
   Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.
   Lancet. 2023 Oct 16:S0140-6736(23)01523-4. doi: 10.1016/S0140-6736(23)01523.
   

   >> Share

   
   
2. DE WIT N, Keszthelyi D
   Low-dose amitriptyline in irritable bowel syndrome: ready for primary care?
   Lancet. 2023 Oct 16:S0140-6736(23)01725-7. doi: 10.1016/S0140-6736(23)01725.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share